Literature DB >> 30898176

Insulin-like growth factor I, binding proteins -1 and -3, risk of type 2 diabetes and macronutrient intakes in men.

Minna E Similä1, Jukka P Kontto1, Jarmo Virtamo1, Katja A Hätönen1, Liisa M Valsta1, Jouko Sundvall1, Satu Männistö1.   

Abstract

The insulin-like growth factor (IGF) axis may be involved in the development of type 2 diabetes. We examined the associations of IGF-I and IGF binding proteins (IGFBP)-1 and -3 with diabetes risk and evaluated macronutrient intakes related to the observed associations. In a nested case-control study of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study of Finnish male smokers aged 50-69 years, the IGF variables were measured from baseline serum samples for a random sample of 310 men with diabetes diagnosed during a 12-year follow-up and for 310 controls matched by age, recruitment day and intervention group. Diet at baseline was assessed using a validated FFQ. The associations of IGF proteins with diabetes risk were estimated using conditional logistic regression and the associations with macronutrient intakes using linear regression. IGF-I and IGFBP-3 were not associated with the incidence of diabetes. Higher IGFBP-1 was associated with lower diabetes risk in an unadjusted crude model (OR 0·25; 95 % CI 0·15, 0·42 in the highest quartile compared with the lowest), but not after adjustment for BMI (corresponding OR 0·76; 95 % CI 0·41, 1·40). Intakes of carbohydrates, plant protein and milk protein associated positively and intake of meat protein and fat negatively with IGFBP-1 (P<0·005). IGFBP-1 was inversely associated with diabetes risk, but the association was substantially dependent on BMI. The associations between macronutrient intakes and IGFBP-1 may reflect influences of nutrients or foods on insulin concentrations.

Entities:  

Keywords:  ATBC Alpha-Tocopherol; Beta-Carotene Cancer Prevention; IGF insulin-like growth factor; IGFBP insulin-like growth factor binding protein; Binding protein; Insulin-like growth factor; Insulin-like growth factor binding proteins; Macronutrients; Type 2 diabetes

Mesh:

Substances:

Year:  2019        PMID: 30898176     DOI: 10.1017/S0007114519000321

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  4 in total

1.  The Impacts of Fish Oil and/or Probiotic Intervention on Low-Grade Inflammation, IGFBP-1 and MMP-8 in Pregnancy: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial.

Authors:  Noora Houttu; Kati Mokkala; Ella Koivuniemi; Outi Pellonperä; Juuso Juhila; Timo Sorsa; Kirsi Laitinen
Journal:  Biomolecules       Date:  2020-12-22

2.  Birth weight modifies the relation between adulthood levels of insulin-like growth factor-1 and type 2 diabetes: a prospective cohort study.

Authors:  Tingting Geng; Mengying Wang; Xiang Li; Tao Zhou; Hao Ma; Vivian A Fonseca; Woon-Puay Koh; Tao Huang; Yoriko Heianza; Lu Qi
Journal:  BMJ Open Diabetes Res Care       Date:  2021-01

3.  Circulating insulin-like growth factor-I and risk of 25 common conditions: outcome-wide analyses in the UK Biobank study.

Authors:  Keren Papier; Anika Knuppel; Aurora Perez-Cornago; Eleanor L Watts; Tammy Y N Tong; Julie A Schmidt; Naomi Allen; Timothy J Key; Ruth C Travis
Journal:  Eur J Epidemiol       Date:  2021-11-08       Impact factor: 8.082

4.  IGF-1 and cardiometabolic diseases: a Mendelian randomisation study.

Authors:  Susanna C Larsson; Karl Michaëlsson; Stephen Burgess
Journal:  Diabetologia       Date:  2020-06-16       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.